S.A.S. Nagar

राष्ट्रीय औषधीय शिक्षा एवं अनुसंधान संस्थान (नाईपर), एस.ए.एस. नगर

National Institute of Pharmaceutical Education and Research (NIPER) S.A.S. Nagar

Sector 67, S.A.S. Nagar (Mohali)-160062, Punjab (India). Phone: +91-172-2214682-87, Fax:+91-172-2214692



195 Aaghaz S, Gohel V, Kamal A. Peptides as Potential Anticancer Agents. Current Topics in Medicinal Chemistry 2019, : .
194 Iyengar ARS, Pande AH. Is human Paraoxonase 1 the saviour against the persistent threat of Organophosphorus nerve agents?. Protein & Peptide Letters2019, : .
193 Kesharwani SS, Kaur S, Tummala H, Sangamwar AT. Multifunctional approaches utilizing polymeric micelles to circumvent multidrug resistant tumors. Colloids and Surfaces B: Biointerfaces 2019, 173: 581-590.
192 Kuche K, Bhargavi N, Dora CP, Jain S. Drug-Phospholipid Complex—a Go Through Strategy for Enhanced Oral Bioavailability. AAPS PharmSciTech 2019, 20: 43.
191 Negi CK, Jena G. Nrf2, a novel molecular target to reduce type 1 diabetes associated secondary complications: The basic considerations. European Journal of Pharmacology 2019, 843: 12-26.
190 Raut SY, Manne ASN, Kalthur G, Jain S, Mutalik S. Cyclodextrins As Carriers In Targeted Delivery Of Therapeutic Agents: Focused Review On Traditional And Inimitable Applications. Current Pharmaceutical Design 2019, : .
189 Dwivedee BP, Soni S, Sharma M, Bhaumik J, Laha JK, Banerjee UC. Promiscuity of Lipase-Catalyzed Reactions for Organic Synthesis: A Recent Update.ChemistrySelect 2018, 3: 2441-2466.
188 Gupta MN, Roy I. Rear Mirror View of Some Biological Tools and Processes. Proceedings of the Indian National Science Academy 2018, 84: 611-624.
187 Kapoor B, Gupta R, Singh SK, Gulati M, Singh S. Prodrugs, phospholipids and vesicular delivery - An effective triumvirate of pharmacosomes. Advances in Colloid and Interface Science 2018, 253: 35-65.
186 Kaur N, Narang A, Bansal AK. Use of biorelevant dissolution and PBPK modeling to predict oral drug absorption. European Journal of Pharmaceutics and Biopharmaceutics 2018, 129: 222-246.
185 Kumar V, Patel S, Jain R. New structural classes of antituberculosis agents. Medicinal Research Reviews 2018, 38: 684-740.
184 Mandal S, Bera T, Dubey G, Saha J, Laha JK. Uses of K2S2O8 in Metal Catalyzed and Metal Free Oxidative Transformations. ACS Catalysis 2018, 8: 5085-5144.
183 Prasad S, Roy I. Converting Enzymes into Tools of Industrial Importance. Recent Patents on Biotechnology 2018, 12: 33-56.
182 Sharma K, Aaghaz S, Shenmar K, Jain R. Short Antimicrobial Peptides. Recent Patents on Anti-Infective Drug Discovery 2018, 13: 12-52.
181 Singh DK, Sahu A, Kumar S, Singh S. Critical review on establishment and availability of impurity and degradation product reference standards, challenges faced by the users, recent developments, and trends. TrAC Trends in Analytical Chemistry 2018, 101: 85-107.
180 Srinivasan, K, Sharma, SS. Endocrine pharmacology research in India: Scientific progress in last five years. Proceedings of the Indian National Science Academy 2018, 84: 73-100.
179 Jena GB, Chavan S. Implementation of Good Laboratory Practices (GLP) in basic scientific research: Translating the concept beyond regulatory compliance.Regulatory Toxicology and Pharmacology 2017, 89: 20-25.
178 Patel KA, Sethi R, Dhara AR, Roy I. Challenges with osmolytes as inhibitors of protein aggregation: Can nucleic acid aptamers provide an answer?.International Journal of Biological Macromolecules 2017, 100: 75-88.
177 Seth K, Purohit P, Chakraborti AK. Microwave Assisted Synthesis of Biorelevant Benzazoles. Current Medicinal Chemistry 2017, 24: 4638-4676.
176 Singh IP, Kumar S, Gupta S. Naphthyridines with Antiviral Activity - A Review. Medicinal Chemistry 2017, 13: 430-438.
175 Iyengar AR, Pande AH. Organophosphate-Hydrolyzing Enzymes as First-Line of Defence Against Nerve Agent-Poisoning: Perspectives and the Road Ahead.The Protein Journal 2016, 35: 424-439.
174 Khan S, Ahirwar K, Jena G. Anti-fibrotic effects of valproic acid: role of HDAC inhibition and associated mechanisms. Epigenomics 2016, 8: 1087-101.
173 Khan S, Bhat ZR, Jena G. Role of autophagy and histone deacetylases in diabetic nephropathy: Current status and future perspectives. Genes & Diseases 2016, 3: 211-219.
172 Parikh N, Chakraborti AK. Phosphodiesterase 4 (PDE4) Inhibitors in the Treatment of COPD: Promising Drug Candidates and Future Directions. Current Medicinal Chemistry 2016, 23: 129-41.
171 Patel NK, Jaiswal G, Bhutani KK. A review on biological sources, chemistry and pharmacological activities of pinostrobin. Natural Product Research 2016, 30: 2017-2027.
170 Bulani Y, Sharma SS. Therapeutic Potential of Targeting Protease Activated Receptors in Cardiovascular Diseases. Current Pharmaceutical Design 2015, 21: 4392-4399.
169 Jadhavar PS, Vaja MD, Dhameliya TM, Chakraborti AK. Oxazolidinones as Anti-tubercular Agents: Discovery, Development and Future Perspectives. Current Medicinal Chemistry 2015, 22: 4379-4397.
168 Khan S, Jena G. The role of butyrate, a histone deacetylase inhibitor in diabetes mellitus: experimental evidence for therapeutic intervention. Epigenomics 2015, 7: 669-80.
167 Kharatmal SB, Singh JN, Sharma SS. Voltage-Gated Sodium Channels as Therapeutic Targets for Treatment of Painful Diabetic Neuropathy. Mini Reviews in Medicinal Chemistry 2015, 15: 1134-1147.
166 Sharma M, Akhtar N, Sambhav K, Shete G, Bansal AK, Sharma SS. Emerging potential of citrus flavanones as an antioxidant in diabetes and its complications.Current Topics in Medicinal Chemistry 2015, 15: 187-195.
165 Dara A, Sangamwar AT. Anticancer patent landscape and technology assessment of Indian public-funded research institutes and organizations. Expert Opinion on Therapeutic Patents 2014, 24: 893-912.
164 Jain S, Rathod V, Prajapati R, Nandekar PP, Sangamwar AT. Pregnane X Receptor and P-glycoprotein: a connexion for Alzheimer's disease management.Molecular Diversity 2014, 18: 895-909.
163 Jain V, Bharatam PV. Pharmacoinformatic approaches to understand complexation of dendrimeric nanoparticles with drugs. Nanoscale 2014, 6: 2476-2501.
162 Mishra S, Aeri V, Gaur PK, Jachak SM. Phytochemical, therapeutic, and ethnopharmacological overview for a traditionally important herb: Boerhavia diffusa Linn. BioMed Research International 2014, 2014: Article ID 808302.
161 Narayanam M, Handa T, Sharma P, Jhajra S, Muthe PK, Dappili PK, Shah RP and Singh S. Critical practical aspects in the application of liquid chromatography-mass spectrometric studies for the characterization of impurities and degradation products. Journal of Pharmaceutical and Biomedical Analysis 2014, 87: 191-217.
160 Sharma M and Garg P. Computational Approaches for Enzyme Functional Class Prediction: A Review. Current Proteomics 2014, 11: 17-22.
159 Tarate B, Chavan R, Bansal AK. Oral solid self-emulsifying formulations: a patent review. Recent Patents on Drug Delivery & Formulation 2014, 8: 126-143.
158 Arfeen M and Bharatam PV. Design of Glycogen Synthase Kinase-3 Inhibitors: An Overview on Recent Advancements. Current Pharmaceutical Design2013, 19: 4755-4775.
157 Dixit VA and Bharatam PV. SAR and Computer-Aided Drug Design Approaches in the Discovery of Peroxisome Proliferator-Activated Receptor γ Activators: A Perspective. Journal of Computational Medicine 2013, 2013: Article ID 406049.
156 Kumar A, Negi G and Sharma SS. Neuroprotection by resveratrol in diabetic neuropathy: concepts & mechanisms. Current Medicinal Chemistry 2013, 20: 4640-4645.
155 Mahajan S and Singh IP. Berberine and its derivatives: a patent review (2009 - 2012). Expert Opinion on Therapeutic Patents 2013, 23: 215-231.
154 Mishra N, Yadav NP, Rai VK, Sinha P, Yadav KS, Jain S, Arora S. Efficient Hepatic Delivery of Drugs: Novel Strategies and Their Significance. BioMed Research International 2013, 2013: Article ID 382184.
153 Rathod V, Jain S, Nandekar PP and Sangamwar AT. Human pregnane X receptor: A novel target for anticancer drug development. Drug Discovery Today2013, 19: 63-70.
152 Thanki K, Gangwal R, Sangamwar AT and Jain S. Oral delivery of anticancer drugs: Challenges and opportunities. Journal of Controlled Release 2013, 170: 15-40.
151 Bansal P and Ajay D. Laboratory dialysis-past, present and future. Recent Patents on Biotechnology 2012, 6: 32-44.
150 Ghosh S, Chisti Y and Banerjee UC. Production of shikimic acid. Biotechnology Advances 2012, 30: 1425-1431.
149 Jena G, Trivedi PP and Sandala B. Oxidative stress in ulcerative colitis: an old concept but a new concern. Free Radical Research 2012, 46: 1339-45.
148 Nandekar PP and Sangamwar AT. Cytochrome P450 1A1-mediated anticancer drug discovery: in silico findings. Expert Opinion on Drug Discovery 2012, 7: 771-789.
147 Singh S, Handa T, Narayanam M, Sahu A, Junwal M and Shah RP. A critical review on the use of modern sophisticated hyphenated tools in the characterization of impurities and degradation products. Journal of Pharmaceutical and Biomedical Analysis 2012, 69: 148-173.
146 Sobhia ME, Paul S, Shinde R, Potluri M, Gundam V, Kaur A and Haokip T. Protein tyrosine phosphatase inhibitors: a patent review (2002 - 2011). Expert Opinion on Therapeutic Patents 2012, 22: 125-153.
145 Agarwal A, Banerjee A and Banerjee UC. Xanthine oxidoreductase: A journey from purine metabolism to cardiovascular excitation-contraction coupling. Critical Reviews in Biotechnology 2011, 31: 264-280.
144 Jain AK, Das M, Swarnakar NK and Jain S. Engineered PLGA nanoparticles: An emerging delivery tool in cancer therapeutics. Critical Reviews in Therapeutic Drug Carrier Systems 2011, 28: 1-45.
143 Jain JP, Ayen WY and Kumar N. Self Assembling Polymers as Polymersomes for Drug Delivery. Current Pharmaceutical Design 2011, 17: 65-79.
142 Negi G, Kumar A, Joshi RP and Sharma SS. Oxidative stress and Nrf2 in the pathophysiology of diabetic neuropathy: Old perspective with a new angle.Biochemical and Biophysical Research Communications 2011, 408: 1-5.
141 Prajapati KD, Sharma SS and Roy N. Current perspectives on potential role of albumin in neuroprotection. Reviews in the Neurosciences 2011, 22: 355-363.
140 Prasad B, Garg A, Takwani H and Singh S. Metabolite identification by liquid chromatography-mass spectrometry. TrAC Trends in Analytical Chemistry 2011, 30: 360-387.
139 Singh IP and Chauthe S. Small molecule HIV entry inhibitors - Part I: Chemokine receptor antagonists: 2004-2010. Expert Opinion on Therapeutic Patents2011, 21: 227-269.
138 Singh IP and Chauthe S. Small molecule HIV entry inhibitors - Part II: Attachment and fusion inhibitors: 2004-2010. Expert Opinion on Therapeutic Patents2011, 21: 399-416.
137 Verma S, Domb AJ and Kumar N. Nanomaterials for regenerative medicine. Nanomedicine 2011, 6: 157-181.
136 Bhutani KK and Gohil VM. Natural products drug discovery research in India: status and appraisal. Indian Journal of Experimental Biology 2010, 48: 199-207.
135 Chakraborti AK, Garg SK, Kumar R, Motiwala HF and Jadhavar PS. Progress in COX-2 Inhibitors: A Journey So Far. Current Medicinal Chemistry 2010, 17: 1563-1593.
134 Kaur K, Jain M, Reddy RP and Jain R. Quinolines and structurally related heterocycles as antimalarials. European Journal of Medicinal Chemistry 2010, 45: 3245-3264.
133 Singh IP and Bodiwala HS. Recent advances in anti-HIV natural products. Natural Product Reports 2010, 27: 1781-1800.
132 Singh IP, Sidana J, Bharate SB and Foley WJ. Phloroglucinol compounds of natural origin: Synthetic aspects. Natural Product Reports 2010, 27: 393-416.
131 Sobhia ME and Singh R. Rational design of CCR2 antagonists: A survey of computational studies. Expert Opinion on Drug Discovery 2010, 5: 543-547.
130 Vikram A, Jena GB and Ramarao P. Insulin-resistance and benign prostatic hyperplasia: The connection. European Journal of Pharmacology 2010, 641: 75-81.
129 Ayenew Z, Puri V, Kumar L and Bansal AK. Trends in pharmaceutical taste masking technologies: a patent review. Recent Patents on Drug Delivery & Formulation 2009, 3: 26-39.
128 Gautam R and Jachak SM. Recent developments in anti-inflammatory natural products. Medicinal Research Reviews 2009, 29: 767-820.
127 Jain NK and Roy I. Effect of trehalose on protein structure. Protein Science 2009, 18: 24-36.
126 Jain S, Dani P and Sharma RK. Pharmacoscintigraphy: a blazing trail for the evaluation of new drugs and delivery systems. Critical Reviews in Therapeutic Drug Carrier Systems 2009, 26: 373-426.
125 Kaur K, Jain M, Kaur T and Jain R. Antimalarials from nature. Bioorganic & Medicinal Chemistry 2009, 17: 3229-3256.
124 Khan SA, Rashmi, Hussain MZ, Prasad S and Banerjee UC. Prospects of biodiesel production from microalgae in India. Renewable and Sustainable Energy Reviews 2009, 13: 2361-2372.
123 Singh IP, Sidana J, Bansal P and Foley WJ. Phloroglucinol compounds of therapeutic interest: global patent and technology status. Expert Opinion on Therapeutic Patents 2009, 19: 847-866.
122 Singh S, Prasad B, Savaliya AA, Shah RP, Gohil VM and Kaur A. Strategies for characterizing sildenafil, vardenafil, tadalafil and their analogues in herbal dietary supplements, and detecting counterfeit products containing these drugs. TrAC Trends in Analytical Chemistry 2009, 28: 13-28.
121 Adane L and Bharatam PV. Modelling and informatics in the analysis of P. falciparum DHFR enzyme inhibitors. Current Medicinal Chemistry 2008, 15: 1552-1569.
120 Gulati M, Singh S, Chopra D, Duggal S and Kumar R. Use of liposomal drugs in the treatment of rheumatoid arthritis. Current Rheumatology Reviews 2008, 4: 63-70.
119 Hiwale P, Amin A, Kumar L and Bansal AK. Variables affecting reconstitution time of dry powder for injection. Pharmaceutical Technology 2008, 32: 62-68.
118 Honrao C, Banerjee UC and Bansal P. IPR and Technological Issues regarding a biopharmaceutical formulation-hemoglobin. Recent Patents on Biotechnology2008, 2: 60-67.
117 Jain JP, ChitkaraD, and Kumar N. Polyanhydrides as localized drug carrier: An update. Expert Opinion on Drug Delivery 2008, 5: 889-907.
116 Jain JP, Sokolsky M, Kumar N and Domb AJ. Fatty acid based biodegradable polymers. Polymer Reviews 2008, 48: 156-191.
115 Kaur G and Roy I. Therapeutic applications of aptamers. Expert Opinion on Investigational Drugs 2008, 17: 43-60.
114 Kumar L, Amin A and Bansal AK. Salt selection in drug development. Pharmaceutical Technology 2008, 32: 128-146.
113 Kumar V, Prasad B and Singh S. Pharmaceutical issues in the development of a polypill for the treatment of cardiovascular diseases. Drug Discovery Today: Therapeutic Strategies 2008, 5: 63-71.
112 Malik R and Roy I. Design and development of antisense drugs. Expert Opinion on Drug Discovery 2008, 3: 1189-1207.
111 Mohan CG and Gandhi T. Therapeutic potential of voltage gated calcium channels. Mini Reviews in Medicinal Chemistry 2008, 8: 1285-1290.
110 Monga V, Meena CL, Kaur N and Jain R. Chemistry and biology of thyrotropin-releasing hormone (TRH) and its analogs. Current Medicinal Chemistry 2008, 15: 2718-2733.
109 Saklani A and Kutty SK. Plant-derived compounds in clinical trials. Drug Discovery Today 2008, 13: 161-171.
108 Bansal SS, Joshi A and Bansal AK. New dosage formulations for targeted delivery of cyclo-oxygenase-2 inhibitors: Focus on use in the elderly. Drugs and Aging 2007, 24: 441-451.
107 Bharatam PV, Patel DS, Adane L, Mittal A and Sundriyal S. Modeling and informatics in the design of anti diabetic agents. Current Pharmaceutical Design2007, 13: 3518-3530.
106 Bhutani KK, Birari R and Kapat K. Potential anti-obesity and lipid lowering natural products: a review. Natural Product Communications 2007, 2: 331-348.
105 Birari RB and Bhutani KK. Pancreatic lipase inhibitors from natural sources: Unexplored potential. Drug Discovery Today 2007, 12: 879-889.
104 Gautam R, Saklani A and Jachak SM. Indian medicinal plants as a source of antimycobacterial agents. Journal of Ethnopharmacology 2007, 110: 200-234.
103 Jachak SM. PGE synthase inhibitors as an alternative to COX-2 inhibitors. Current Opinion in Investigational Drugs 2007, 8: 411-415.
102 Jachak SM and Saklani A. Challenges and opportunities in drug discovery from plants. Current Science 2007, 92: 1251-1257.
101 Kadam RU and Roy N. Recent trends in drug-likeness prediction: A comprehensive review of in silico methods. Indian Journal of Pharmaceutical Sciences2007, 69: 609-615.
100 Kumar L, Amin A and Bansal AK. An overview of automated systems relevant in pharmaceutical salt screening. Drug Discovery Today 2007, 12: 1046-1053.
99 Mital A. Recent advances in antimalarial compounds and their patents. Current Medicinal Chemistry 2007, 14: 759-773.
98 Mohan CG, Gandhi T, Garg D, and Shinde R. Computer assisted methods in chemical toxicity prediction. Mini Reviews in Medicinal Chemistry 2007, 7: 499-507.
97 Patel DS, Dessaalew, Iqbal P and Bharatam PV. Structure-based approaches in the design of GSK-3 selective inhibitors. Current Protein and Peptide Science2007, 8: 352-364.
96 Roy I, Mondal K and Gupta MN. Leveraging protein purification strategies in proteomics. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences 2007, 849: 32-42.
95 Amin A and Bansal AK. Formulation development for sterile liquid products in blow-fill-seal packs. Pharmaceutical Technology 2006, 30: 142-154.
94 Chitkara D, Shikanov A, Kumar N and Domb AJ. Biodegradable Injectable In Situ Depot Forming Drug Delivery Systems. Macromolecular Biosciences 2006, 6: 977-990.
93 Italia JL, Bhardwaj V and Ravi Kumar MNV. Disease, destination, dose and delivery aspects of ciclosporin: the state of the art. Drug Discovery Today 2006, 11: 846-854.
92 Jachak SM. Cyclooxygenase inhibitory natural products: current status. Current Medicinal Chemistry 2006, 13: 659-678.
91 Modi S, Prakash Jain J, Domb AJ and Kumar N. Exploiting EPR in polymer drug conjugate delivery for tumor targeting. Current Pharmaceutical Design 2006, 12: 4785-4796.
90 Patel S, Kaushal AM and Bansal AK. Compression physics in the formulation development of tablets. Critical Reviews in Therapeutic Drug Carrier Systems2006, 23: 1-65.
89 Paul AT, Gohil VM and Bhutani KK. Modulating TNF-alpha signaling with natural products. Drug Discovery Today 2006, 11: 725-732.
88 Ramachandran U, Kumar R and Mittal A. Fine tuning of PPAR ligands for type 2 diabetes and metabolic syndrome. Mini Reviews in Medicinal Chemistry2006, 6: 563-573.
87 Ratnam DV, Ankola DD, Bhardwaj V, Sahana DK and Ravi Kumar MNV. Role of antioxidants in prophylaxis and therapy: A pharmaceutical perspective.Journal of Controlled Release 2006, 113: 189-207.
86 Shah B, Kakumanu VK and Bansal AK. Analytical techniques for quantification of amorphous/crystalline phases in pharmaceutical solids. Journal of Pharmaceutical Sciences 2006, 95: 1641-1665.
85 Sharma G, Anabousi S, Ehrhardt C and Ravi Kumar MNV. Liposomes as targeted drug delivery systems in the treatment of breast cancer. Journal of Drug Targeting 2006, 14: 301-310.
84 Singh IP and Bharate SB. Phloroglucinol compounds of natural origin. Natural Product Reports 2006, 23: 558-591.
83 Singh PP. Malaria and macrophages: Cellular and molecular basis of pathogenesis and immune protection. Journal of Parasitic Diseases 2006, 30: 116-124.
82 Singh S and Kumar V. Recent developments on long-term stability test conditions. The Pharma Review 2006, 5: 61-68.
81 Sundriyal S, Sharma RK and Jain R. Current advances in antifungal targets and drug development. Current Medicinal Chemistry 2006, 13: 1321-1335.
80 Tripathy CB and Roy N. Meta-analysis of glutathione S-transferase M1 genotype and risk toward head and neck cancer. Head Neck 2006, 28: 217-224.
79 Vangapandu S, Jain M, Kaur K, Patil P, Patel SR and Jain R. Recent advances in antimalarial drug development. Medicinal Research Reviews 2006, 27: 65-107.
78 Arun KHS and Ramarao P. Saga of Renin-Angiotensin System and Calcium Channels in Hypertensive Diabetics: Does it Have a Therapeutic Edge?.Cardiovascular Drug Reviews 2005, 23: 99-114.
77 Arun KHS, Kaul CL and Ramarao P. Green fluorescent proteins in receptor research: an emerging tool for drug discovery. Journal of Pharmacological and Toxicological Methods 2005, 51: 1-23.
76 Bansal AK and Koradia V. The role of reverse engineering in the development of generic formulations. Pharmaceutical Technology 2005, 29: 50-55.
75 Gandhi R, Ashokraj Y, Kaul CL and Panchagnula R. Using extrusion-spheronization to develop: Controlled-release formulations of azithromycin. Pharmaceutical Technology 2005, 29: 68-86.
74 Jain JP, Modi S, Domb AJ and Kumar N. Role of polyanhydrides as localized drug carriers. Journal of Controlled Release 2005, 103: 541-563.
73 Jain R and Chawrai S. Advancements in the anti-diabetes chemotherapeutics based on amino acids, peptides, and peptidomimetics. Mini Reviews in Medicinal Chemistry 2005, 5: 469-477.
72 Jena GB, Kaul CL and Ramarao P. Regulatory requirements and ICH guidelines on carcinogenicity testing of pharmaceuticals: A review on current status.Indian Journal of Pharmacology 2005, 37: 209-222.
71 Kashyap N, Kumar N and Ravi Kumar MNV. Hydrogels for pharmaceutical and biomedical applications. Critical Reviews in Therapeutic Drug Carrier Systems 2005, 22: 107-150.
70 Kumar N, Bentolila A and Domb AJ. Structure and biological activity of heparinoid. Mini Reviews in Medicinal Chemistry 2005, 5: 441-447.
69 Nayyar A and Jain R. Recent advances in new structural classes of anti-tuberculosis agents. Current Medicinal Chemistry 2005, 12: 1873-1886.
68 Rai HS, Bansal TK, Bhattacharyya MS, Banerjee UC, Singh J and Vats P. Removal of dyes from the effluent of textile and dyestuff manufacturing industry: A review of emerging techniques with reference to biological treatment. Critical Reviews in Environmental Science and Technology 2005, 35: 219-238.
67 Singh IP, Bharate SB and Bhutani KK. Anti-HIV natural products. Current Science 2005, 89: 269-290.
66 Singh IP, Bharate SB and Bhutani KK. Interaction of herbs and food products with drugs: Grape fruit juice as an example. Natural Product Radiance 2005, 4: 107-112.
65 Singh M, Singh S, Dubey S, Soni P and Banerjee UC. Influence of process parameters on the production of metabolites in solid-state fermentation. Malaysian Journal of Microbiology 2005, 1: 1-9.
64 Singh S, Kate BN and Banerjee UC. Bioactive compounds from cyanobacteria and microalgae: an overview. Critical Reviews in Biotechnology 2005, 25: 73-95.
63 Sonkusare SK, Kaul CL and Ramarao P. Dementia of Alzheimer's disease and other neurodegenerative disorders�memantine, a new hope. Pharmacological Research 2005, 51: 1-17.
62 Vats P, Bhattacharyya MS and Banerjee UC. Use of phytases (myo-inositolhexakisphosphate phosphohydrolases) for combatting environmental pollution: A biological approach. Critical Reviews in Environmental Science and Technology 2005, 35: 469-486.
61 Vats RK, Kumar V, Kothari A, Mital A and Ramachandran U. Emerging targets for diabetes. Current Science 2005, 88: 241-249.
60 Bala I, Hariharan S and Ravi Kumar MNV. PLGA Nanoparticles in Drug Delivery: The State of the Art. Critical Reviews in Therapeutic Drug Carrier Systems 2004, 21: 387-422.
59 Banerjee A, Chisti Y and Banerjee UC. Streptokinase-a clinically useful thrombolytic agent. Biotechnology Advances 2004, 22: 287-307.
58 Kalia V, Jadhav AN and Bhutani KK. Luteinizing hormone estimation. Endocrine Research 2004, 30: 1-17.
57 Kaushal AM, Gupta P and Bansal AK. Amorphous drug delivery systems: Molecular aspects, design and performance. Critical Reviews in Therapeutic Drug Carrier Systems 2004, 21: 133-193.
56 Nachaegari SK and Bansal AK. Coprocessed excipients for solid dosage forms. Pharmaceutical Technology (North America) 2004, 28: 52-64.
55 Panchagnula R and Agrawal S. Biopharmaceutic and pharmacokinetic aspects of variable bioavailability of Rifampicin. International Journal of Pharmaceutics2004, 271: 1-4.
54 Panchagnula R, Agrawal S, Ashokraj Y, Varma M, Khandavilli S, Bhardwaj V, Bedi S, Gulati I, Parmar J, Kaul CL, Blomberg B, Fourie B, Roscigno G, Wire R, Laing R, Evans P and Moore T. Fixed dose combinations for tuberculosis: Lessons learned from clinical, formulation and regulatory perspective. Methods and Findings in Experimental and Clinical Pharmacology 2004, 26: 703-721.
53 Ramachandran U and Sharma M. Patent stakes of Indian pharmaceutical industry. The Pharma Review 2004, 2: 19-27.
52 Ravi Kumar MNV, Hellerman G, Lockey RF and Mohapatra SS. Nanoparticle-mediated gene delivery: the state of the art. Expert Opinion on Biological Therapy 2004, 4: 1213-1224.
51 Ravi Kumar MNV, Muzzarelli RA, Muzzarelli C, Sashiwa H and Domb AJ. Chitosan chemistry and pharmaceutical perspectives. Chemical Reviews 2004, 104: 6017-6084.
50 Tamilvanan S. Oil-in-water lipid emulsions: implications for parenteral and ocular delivering systems. Progress in Lipid Research 2004, 43: 489-533.
49 Tamilvanan S and Benita S. The potential of lipid emulsion for ocular delivery of lipophilic drugs. European Journal of Pharmaceutics and Biopharmaceutics2004, 58: 357-368.
48 Varma MVS, Khandavilli S, Ashokraj Y, Jain A, Dhanikula A, Sood A, Narisetty ST, Pillai O, Sharma P, Gandhi R, Agrawal S, Nair VB and Panchagnula R.Biopharmaceutic classification system: A scientific framework for pharmacokinetic optimization in drug research. Current Drug Metabolism 2004, 5: 375-388.
47 Vats P and Banerjee UC. Production studies and catalytic properties of phytases (myo-inositolhexakisphosphate phosphohydrolases): an overview. Enzyme and Microbial Technology 2004, 35: 3-14.
46 Verma NK and Dey CS. RNA Mediated gene silencing: mechanisms and its therapeutic applications. Journal of Clinical Pharmacy and Therapeutics 2004, 29: 395-404.
45 Verma RK, Arora S and Garg S. Osmotic pumps in drug delivery. Critical Reviews in Therapeutic Drug Carrier Systems 2004, 21: 477-520.
44 Bhutani KK. Herbal medicines- an enigma and challenge to science and directions for future initiatives. Indian Journal of Natural Product 2003, 19: 3-10.
43 Chawla G, Gupta P, Koradia V and Bansal AK. Gastroretention - a means to address regional variability in intestinal drug absorption. Pharmaceutical Technology (North America) 2003, 27: 50-68.
42 Garg S, Raghupathi K, Vermani K, Tambwekar KR, Garg A, Waller DP and Zaneveld LJD. Development Pharmaceutics of Microbicide Formulations Part I: Preformulation Considerations and Challenges. AIDS Patient Care and STDs 2003, 17: 17-32.
41 Garg S, Tambwekar KR, Vermani K, Raghupathi K, Garg A, Waller DP and Zaneveld LJD. Development Pharmaceutics of Microbicide Formulations Part II: Formulation, Evaluation, and Challenges. AIDS Patient Care and STDs 2003, 17: 377-399.
40 Singal P and Singh PP. Cellular and cytokine responses in Leishmaniasis. Journal of Parasitic Diseases 2003, 27: 1-12.
39 Tambwekar KR, Madhuri V, Kakaria RB, Garg S. An Update On Pharmacotherapies Of Smoking Cessation. Indian Journal of Pharmaceutical Sciences2003, 65: 450-460.
38 Vasir JK, Tambwekar K and Garg S. Bioadhesive microspheres as a controlled drug delivery system. International Journal of Pharmaceutics 2003, 255: 13-32.
37 Verma MVS, Ashokrai Y, Dey, CS and Panchagnula R. P-glycoprotein inhibitors and their screening: a perspective from bioavailability enhancement.Pharmacological Research 2003, 48: 347-359.
36 Arora P, Sharma S and Garg S. Permeability issues in nasal drug delivery. Drug Discovery Today 2002, 7: 967-975.
35 Bakshi M and Singh S. Development of validated stability-indicating assay methods—critical review. Journal of Pharmaceutical and Biomedical Analysis2002, 28: 1011-1040.
34 Banerjee A, Sharma R, Chisti Y and Banerjee UC. Botryococcus braunii: a renewable source of hydrocarbons and other chemicals. Critical Reviews in Biotechnology 2002, 22: 245-279.
33 Bansal AK. Product development issues of powders for injection. Pharmaceutical Technology 2002, 26: 122-132.
32 Gupta P, Vermani K and Garg S. Hydrogels: from controlled release to pH-responsive drug delivery. Drug Discovery Today 2002, 7: 569-579.
31 Jayanarayan KG and Dey CS. Microtubules: Dynamics, drug interaction and drug resistance in Leishmania. Journal of Clinical Pharmacy and Therapeutics2002, 27: 313-320.
30 Singh S, Rao KVR, Venugopal K and Manikandan R. Alteration in dissolution characteristics of gelatin-containing formulations: a review of the problem, test methods, and solutions. Pharmaceutical Technology 2002, 26: 36-58.
29 Thiyagarajan M. α-Adrenoceptor antagonists in the treatment of benign prostate hyperplasia. Pharmacology 2002, 65: 119-128.
28 Verma RK, Krishna DM and Garg S. Formulation aspects in the development of osmotically controlled oral drug delivery systems. Journal of Controlled Release 2002, 79: 7-27.
27 Vermani K and Garg S. Herbal medicines for sexually transmitted diseases and AIDS. Journal of Ethnopharmacology 2002, 80: 49-66.
26 Agrawal S, Thomas NS, Dhanikula AB, Kaul CL and Panchagnula R. Antituberculosis drugs and new drug development. Current Opinion in Pulmonary Medicine 2001, 7: 142-147.
25 Garg A, Garg S, Zaneveld L and Singla A. An update on the chemistry and pharmacology of the citrus bioflavanoid-hesperidin. Phytotherapy Research 2001, 15: 655-669.
24 Kaul CL and Ramarao P. The role of aldose reductase inhibitors in diabetic complications: recent trends. Methods and Findings in Experimental and Clinical Pharmacology 2001, 23: 465-475.
23 Panchagnula R, Agrawal S and Kaul CL. Fixed dose combinations in treatment of tuberculosis. Indian Journal of Pharmaceutical Sciences 2001, 63: 1-9.
22 Pillai O and Panchagnula R. Polymers in drug delivery. Current Opinion in Chemical Biology 2001, 5: 447-451.
21 Pillai O, Dhanikula AB and Panchagnula R. Drug delivery: an odyssey of 100 years. Current Opinion in Chemical Biology 2001, 5: 439-446.
20 Pillai O, Nair V, Jain AK, Thomas NS and Panchagnula R. Noninvasive transdermal delivery of peptides and proteins. Drugs of the future 2001, 26: 779-791.
19 Singh S, Mariappan TT, Shankar R, Sharda N and Singh B. A critical review of the probable reasons for the poor variable bioavailability of rifampicin from anti-tubercular fixed-dose combination (FDC) products, and the likely solutions to the problem. International Journal of Pharmaceutics 2001, 228: 5-17.
18 Sood A and Panchagnula R. Peroral route: an opportunity for protein and peptide drug delivery. Chemical Reviews 2001, 101: 3275-3303.
17 Geetha T and Singh S. Applications of immobilized stationary-phase liquid chromatography: a potential in vitro technique. Pharmaceutical Science & Technology Today 2000, 3: 406-416.
16 Grover M, Singh B, Bakshi M and Singh S. Quantitative structure-property relationships in pharmaceutical research - Part 1. Pharmaceutical Science & Technology Today 2000, 3: 28-35.
15 Grover M, Singh B, Bakshi M and Singh S. Quantitative structure-property relationships in pharmaceutical research - Part 2. Pharmaceutical Science & Technology Today 2000, 3: 50-57.
14 Jain AK and Panchagnula R. Skeletal drug delivery systems. International Journal of Pharmaceutics 2000, 206: 1-12.
13 Panchagnula R and Thomas NS. Biopharmaceutics and pharmacokinetics in drug research. International Journal of Pharmaceutics 2000, 201: 131-150.
12 Panchagnula R, Jain AK, Pillai O and Jaiswal J. Nicotine transdermal systems: pharmaceutical and clinical aspects. Methods and Findings in Experimental and Clinical Pharmacology 2000, 22: 299-308.
11 Panchagnula R, Pillai O, Nair VB and Ramarao P. Transdermal Iontophoresis revisited. Current Opinion in Chemical Biology 2000, 4: 468-473.
10 Singh S and Bakshi M. Guidance on conduct of stress tests to determine inherent stability of drugs. Pharmaceutical Technology Asia 2000, Sep: 24-36.
9 Dhanikula AB and Panchagnula R. Localized paclitaxel delivery. International Journal of Pharmaceutics 1999, 183: 85-100.
8 Nair V, Pillai O, Ramarao P and Panchagnula R. Transdermal Iontophoresis. Part I: Basic Principles and Considerations. Methods and Findings in Experimental and Clinical Pharmacology 1999, 21: 139-151.
7 Pillai O, Nair V, Ramarao P and Panchagnula R. Transdermal Iontophoresis. Part II: Peptide and Protein Delivery. Methods and Findings in Experimental and Clinical Pharmacology 1999, 21: 229-240.
6 Sharma P, Chawla HPS and Panchagnula R. The role of sorption promoters in increasing the bioavailability of drugs in oral preparations. Drugs of the future1999, 24: 1221-1240.
5 Gulati M, Bajaj S, Singh S, Ferdous AJ and Singh M. Development of liposomal amphotericin formulation. Journal of Microencapsulation 1998, 15: 137-151.
4 Gulati M, Grover M, Singh S and Singh M. Lipophilic drug derivatives in liposomes. International Journal of Pharmaceutics 1998, 165: 129-168.
3 Panchagnula R. Pharmaceutical aspects of paclitaxel. International Journal of Pharmaceutics 1998, 172: 1-15.
2 Panchagnula R. Transdermal delivery of drugs. Indian Journal of Pharmacology 1997, 29: 140-156.
1 Panchagnula R and Dey CS. Monoclonal antibodies in drug targeting. Journal of Clinical Pharmacy and Therapeutics 1997, 22: 7-19.